Cargando…

Trends in cervical cancer incidence and survival in Estonia from 1995 to 2014

BACKGROUND: Cervical cancer (CC) incidence in Estonia is the third highest in Europe, even though an organised nation-wide screening program has been in place since 2006. The aim of the study was to analyse the incidence and survival of CC in Estonia, focusing on age, morphology and stage at diagnos...

Descripción completa

Detalles Bibliográficos
Autores principales: Ojamaa, Kristiina, Innos, Kaire, Baburin, Aleksei, Everaus, Hele, Veerus, Piret
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6222998/
https://www.ncbi.nlm.nih.gov/pubmed/30404606
http://dx.doi.org/10.1186/s12885-018-5006-1
_version_ 1783369338559922176
author Ojamaa, Kristiina
Innos, Kaire
Baburin, Aleksei
Everaus, Hele
Veerus, Piret
author_facet Ojamaa, Kristiina
Innos, Kaire
Baburin, Aleksei
Everaus, Hele
Veerus, Piret
author_sort Ojamaa, Kristiina
collection PubMed
description BACKGROUND: Cervical cancer (CC) incidence in Estonia is the third highest in Europe, even though an organised nation-wide screening program has been in place since 2006. The aim of the study was to analyse the incidence and survival of CC in Estonia, focusing on age, morphology and stage at diagnosis. METHODS: Data from Estonian Cancer Registry were used to analyse age-standardized (world) and age-specific incidence for 1968–2014 rates. Joinpoint regression was used to estimate the annual percentage change (APC) for incidence trends. Age-period-cohort model was used to summarise time trends in terms of cohort and period effects. Relative survival ratios (RSR) were calculated for cases diagnosed in 1995–2014. Union for International Cancer Control version 7 of the TNM classification for malignant tumours was used to categorise stage. RESULTS: The age-standardized incidence of CC increased since 1980s at a rate of 0.8% per year. A significant increase was seen for all age groups except for 70+. The incidence of squamous cell carcinoma mimicked the overall trend, while adenocarcinoma showed increase since mid-1990s (APC 6.7). Age-period-cohort modelling showed strong cohort effects with the lowest risk for birth-cohorts born around 1940 and significantly increasing risks for successive cohorts born thereafter. No period effects were seen. The proportion of stage IV cases increased from 13% in 2005–2009 to 18% in 2010–2014. A significant increase was seen in the overall 5-year RSR from 1995 to 1999 to 2010–2014 (58% vs 66%). In 2010–2014, the 5-year RSRs ranged from 89% in women aged 15–39 to 41% in age group 70+. For stages I to IV, the respective RSRs were 98, 74, 57 and 22%. CONCLUSIONS: The inadequate uptake and insufficient quality of the Pap-smear based screening program has not brought along a decline in the incidence of CC in Estonia. Stage distribution has shifted towards later stages. New approaches are needed to prevent CC in Estonia.
format Online
Article
Text
id pubmed-6222998
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-62229982018-11-19 Trends in cervical cancer incidence and survival in Estonia from 1995 to 2014 Ojamaa, Kristiina Innos, Kaire Baburin, Aleksei Everaus, Hele Veerus, Piret BMC Cancer Research Article BACKGROUND: Cervical cancer (CC) incidence in Estonia is the third highest in Europe, even though an organised nation-wide screening program has been in place since 2006. The aim of the study was to analyse the incidence and survival of CC in Estonia, focusing on age, morphology and stage at diagnosis. METHODS: Data from Estonian Cancer Registry were used to analyse age-standardized (world) and age-specific incidence for 1968–2014 rates. Joinpoint regression was used to estimate the annual percentage change (APC) for incidence trends. Age-period-cohort model was used to summarise time trends in terms of cohort and period effects. Relative survival ratios (RSR) were calculated for cases diagnosed in 1995–2014. Union for International Cancer Control version 7 of the TNM classification for malignant tumours was used to categorise stage. RESULTS: The age-standardized incidence of CC increased since 1980s at a rate of 0.8% per year. A significant increase was seen for all age groups except for 70+. The incidence of squamous cell carcinoma mimicked the overall trend, while adenocarcinoma showed increase since mid-1990s (APC 6.7). Age-period-cohort modelling showed strong cohort effects with the lowest risk for birth-cohorts born around 1940 and significantly increasing risks for successive cohorts born thereafter. No period effects were seen. The proportion of stage IV cases increased from 13% in 2005–2009 to 18% in 2010–2014. A significant increase was seen in the overall 5-year RSR from 1995 to 1999 to 2010–2014 (58% vs 66%). In 2010–2014, the 5-year RSRs ranged from 89% in women aged 15–39 to 41% in age group 70+. For stages I to IV, the respective RSRs were 98, 74, 57 and 22%. CONCLUSIONS: The inadequate uptake and insufficient quality of the Pap-smear based screening program has not brought along a decline in the incidence of CC in Estonia. Stage distribution has shifted towards later stages. New approaches are needed to prevent CC in Estonia. BioMed Central 2018-11-07 /pmc/articles/PMC6222998/ /pubmed/30404606 http://dx.doi.org/10.1186/s12885-018-5006-1 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Ojamaa, Kristiina
Innos, Kaire
Baburin, Aleksei
Everaus, Hele
Veerus, Piret
Trends in cervical cancer incidence and survival in Estonia from 1995 to 2014
title Trends in cervical cancer incidence and survival in Estonia from 1995 to 2014
title_full Trends in cervical cancer incidence and survival in Estonia from 1995 to 2014
title_fullStr Trends in cervical cancer incidence and survival in Estonia from 1995 to 2014
title_full_unstemmed Trends in cervical cancer incidence and survival in Estonia from 1995 to 2014
title_short Trends in cervical cancer incidence and survival in Estonia from 1995 to 2014
title_sort trends in cervical cancer incidence and survival in estonia from 1995 to 2014
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6222998/
https://www.ncbi.nlm.nih.gov/pubmed/30404606
http://dx.doi.org/10.1186/s12885-018-5006-1
work_keys_str_mv AT ojamaakristiina trendsincervicalcancerincidenceandsurvivalinestoniafrom1995to2014
AT innoskaire trendsincervicalcancerincidenceandsurvivalinestoniafrom1995to2014
AT baburinaleksei trendsincervicalcancerincidenceandsurvivalinestoniafrom1995to2014
AT everaushele trendsincervicalcancerincidenceandsurvivalinestoniafrom1995to2014
AT veeruspiret trendsincervicalcancerincidenceandsurvivalinestoniafrom1995to2014